PFIZER AGREEMENT WITH NORTHWESTERN IN ANTI-TRUST SUIT STIPULATES
PFIZER AGREEMENT WITH NORTHWESTERN IN ANTI-TRUST SUIT STIPULATES that the whslr. will not sell Pfizer products to its Pay 'N Save outlets. "Pfizer agreed to sell to Northwestern products at whsle. price where products are not re-sold to Pay 'N Save affiliated outlets," a Pfizer representative told "The Pink Sheet." The mfr. and Northwestern settled the suit on Oct. 12. Pfizer is the fourth company to reach a long-term settlement with Northwestern. Previously, Lilly, American Home Products, and Sandoz reached agreements with the whslr. ("The Pink Sheet" Oct. 1, p. 14). Lilly's agreement calls for the firm to supply Northwestern through June 1985. SmithKline remains as the sole mfr. defendant in the lawsuit. Last May, SmithKline arrived at an interim agreement with Northwestern's customer, the Velocity Hospital Buying Group, to provide normal chargeback allowances, pending the outcome of the suit. The case is scheduled to go to trial on Feb. 25, 1985.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth